
We report on a male patient with an inactive zzso and zzso zzso He presented with zzso at the age of 16 and received growth hormone replacement therapy for one zzso During this period the zzso mass increased substantially and showed subsequently a consistent shrinkage once treatment was zzso The zzso zzso stayed stable for the whole period of zzso The zzso zzso related change of the zzso zzso zzso the importance of careful follow-up of children with growth hormone zzso secondary to treatment for brain zzso zzso therapy with zzso requires further and longer studies before it can be recommended with absolute reassurance in children with zzso zzso of a zzso zzso 

